Analyst Price Target is $16.00
▲ +68.60% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Benitec Biopharma in the last 3 months. The average price target is $16.00, with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 68.60% upside from the last price of $9.49.
Current Consensus is
Buy
The current consensus among 1 contributing investment analysts is to buy stock in Benitec Biopharma. This Buy consensus rating has held steady for over two years.